Welcome to InfiCure Bio
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.
Based on a panel of in vivo models for these conditions including a proprietary model for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.
Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.
InfiCure Bio is happy to announce that the our application for Vinnovas grant "Innovationsprojekt i företag" was funded. In this round of applications, InfiCure Bio was the only company in Västerbotten with an approved application. [...]
Read our new pamphlet on the NIF mouse as a model for studies of liver fibrosis. The NIF mouse can be used both as a model for tests of drugs to treat general liver fibrosis, [...]
The application to Horizon 2020 SME Instrument Phase II submitted by InfiCure Bio i January 2019 was awarded a seal of excellence. This means that the application passed the score set by EU for grant [...]